Search Results for 'Ldl-Placebo'

Ldl-Placebo published presentations and documents on DocSlides.

ODYSSEY FH I and II In FH I:

ODYSSEY FH I and II In FH I:

by Aquamarine

From baseline to 24 weeks, the change in . LDL-C: ...

Trial Design Evolocumab SC

Trial Design Evolocumab SC

by danika-pritchard

140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...

Residual risk: Is LDL target enough?

Residual risk: Is LDL target enough?

by candy

An interpretation of the continuous relationship b...

Lifestyle Tips to Lower Your LDL Cholesterol

Lifestyle Tips to Lower Your LDL Cholesterol

by dandy

Advice f rom the National Lipid Association Clini...

PCSK9 Inhibition: LDL Lowering

PCSK9 Inhibition: LDL Lowering

by SweetiePie

PCSK9 inhibitors. New option for dyslipidemia. Ali...

LDL-CHOLESTEROL Presented By

LDL-CHOLESTEROL Presented By

by williams

Assist.Lecturer. Aseel. . Ghassan. . Daoud. M.Sc...

LDL is causal of atherosclerosis

LDL is causal of atherosclerosis

by morgan

Evidence from . meta-analyses of . Mendelian. . r...

LDL Apheresis in Drug Resistant Nephrotic Syndrome

LDL Apheresis in Drug Resistant Nephrotic Syndrome

by obrien

Rodney D Gilbert. Patient JM. 14 year old girl, pr...

Is lower better? LDL targets and beyond.

Is lower better? LDL targets and beyond.

by olivia-moreira

Implications of the relationship between risk fac...

Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?

Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?

by min-jolicoeur

NICE –CG 181 Continuum of CVD Risk and its trea...

Is lower better? LDL targets and beyond.

Is lower better? LDL targets and beyond.

by trish-goza

Implications of the relationship between risk fac...

Abnormalities of LDL metabolism

Abnormalities of LDL metabolism

by briana-ranney

Physiology, pathophysiology and treatments. Under...

Diabetic dyslipidemia : The pro-

Diabetic dyslipidemia : The pro-

by deborah

atherogenic. role of CETP and future use of CETP ...

LDL Cholesterol Lowering with

LDL Cholesterol Lowering with

by shoffer

Evolocumab. and Outcomes in Patients with . Perip...

Protecting the heart and the kidney:

Protecting the heart and the kidney:

by pressio

Implications from the SHARP trial. Dr. Christina R...

PCSK-9 Inhibitors Paul J

PCSK-9 Inhibitors Paul J

by tatyana-admore

PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...

New developments in lipid management

New developments in lipid management

by pasty-toler

CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....

Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in

Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in

by pamella-moone

Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...

FOURIER F urther cardiovascular

FOURIER F urther cardiovascular

by trish-goza

OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...

Cholesterol Treatment Trialists’ (CTT) Collaboration

Cholesterol Treatment Trialists’ (CTT) Collaboration

by briana-ranney

Slide deck. CTT Collaboration: Background*. Histo...

Novel therapies for the prevention of atherosclerotic vascu

Novel therapies for the prevention of atherosclerotic vascu

by debby-jeon

Prof. . John . Kastelein. Academic Medical Centre...

Protecting the heart and the kidney:

Protecting the heart and the kidney:

by marina-yarberry

Implications from the SHARP trial. Dr. Christina ...

CETP inhibition : Where

CETP inhibition : Where

by rodriguez

are we . now. ?. Prof. John Kastelein. Academic. ...

Placebo (n = 38) Metoprolol

Placebo (n = 38) Metoprolol

by unita

(. n . = 37). Metoprolol for AR. Primary endpoint,...

Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i

Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i

by delcy

syncope. Given the trend towards benefit though, i...

Placebo (n = 2,333) Empaglifozin

Placebo (n = 2,333) Empaglifozin

by SugarPlumFairy

(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...

Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)

Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)

by delcy

MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...

Neratinib / Placebo treatment

Neratinib / Placebo treatment

by heartersh

0. 3. 6. 9. 12. 15. 18. 21. 24. Disease-free survi...

ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular

ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular

by mitsue-stanley

ASCEND Randomized placebo-controlled trial of as...

Causal diagrams, the placebo effect, and the expectation effect

Causal diagrams, the placebo effect, and the expectation effect

by ellena-manuel

Eyal Shahar, MD, MPH. Professor. (. c. redit to D...

Anxiolytic Placebo Response in Outbred Mice

Anxiolytic Placebo Response in Outbred Mice

by natalia-silvester

Kelsey I. . Landaverde. , Stacey L. . Kirkpatrick...

What Accounts for Placebo Group

What Accounts for Placebo Group

by alida-meadow

Improvements and Can They Be Reduced?. John T. Fa...

Does Meditation Really Work or It’s Placebo effect

Does Meditation Really Work or It’s Placebo effect

by ellena-manuel

Simge ALTINKÖK. Outline. Definition of meditati...

The Placebo Effect

The Placebo Effect

by danika-pritchard

. ...

The Placebo Effect

The Placebo Effect

by alexa-scheidler

Homeopathy. In the late 1700’s a German doctor ...

The Placebo Drift Debate in Antidepressant Clinical Trials

The Placebo Drift Debate in Antidepressant Clinical Trials

by celsa-spraggs

Zach Daniel White. Biology 101h- . Desaix. Why do...

SWL lipid management guideline update- Highlights

SWL lipid management guideline update- Highlights

by finley

. Pedro Bandeira. Specialist Pharmacist- Cardiov...

Dyslipidemia (Med-3) Dr Anwar A Jammah

Dyslipidemia (Med-3) Dr Anwar A Jammah

by bety

, MD, FRCPC, FACP, CCD, ECNU.. Associate . Profess...

Fats Cholesterol Saturated Fats

Fats Cholesterol Saturated Fats

by paige

Unsaturated Fats . Trans Fats . Fats. Help the bod...

Lipids and lipoproteins Lipid chemistry and cardiovascular profile

by cadie

Main lipids in the blood are the triglycerides and...